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1. Introduction
  Human cytomegalovirus (HCMV), a member of the 
herpesvirus family, infects the majority of adult population. 
It is reported that approximately 70% of the population 
possess antibodies to HCMVA[1]. Acute infections by 
HCMV in immunocompromised individuals may lead to 
severe hematologic disorders, such as mononucleosis[2,3], 
h e p a t o s p l e n o m e g a l y [ 4 ] ,  l y m p h a d e n o p a t h y , 
thrombocytopenia[5], and hemolytic anemia[6]. Clinically, in 
patients undergoing bone marrow transplants, HCMV may be 
associated with delayed platelet engraftment, phenotypically 
abnormal peripheral blood leukocytes and graft failure[7], 
possibly through a direct viral effect on hematopoietic 
progenitor cells[8]. Furthermore, in vitro HCMV infection has 
shown inhibitory effect on the proliferation and colony-
forming ability of hematopoietic precursors[9,10]. Dang-Gui-
Bu-Xue-Tang(DGBXT), as a classical traditional Chinese 
medicine formula, can invigorate qi and supplement 
blood. It comprises of astragalus 50 g and angelica 10 g. In 
clinic, it is used to treat anemia and help patients recover 
from damage of marrow failure. As other famous ancient 
formulas, decoction is the main formulation. This hampers 
the development of traditional Chinese medicine greatly, 
due to uncontrollability of decoction manner, original place 
of crude drug, picking season, medical location of the plant 
and large dosage of crude drug. It is also inconvenient 
for patients to carry. Granule is a new formulation of the 
traditional Chinese medicine. It is concentrated from a 
single herb plant, and has been widely used in clinic.
This study is to compare the efficacy between a simple 
combination of astragalus granule and angelica granule and 
traditional DGBXT decoction.
2. Materials and methods
2.1. Animal and reagent
  Twenty four BALB/c inbred line male mice(8-12 w,18-22 
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g) were randomly assigned to four groups: DGBXT decoction 
Group, DGBXT granule Group, model group and normal 
control group. Every group had six mice[11].
  Cyclophosphamide was purchased from Shanghai 
Hualian Pharmaceutical Co. 60Co毭 was provided by 
Biotechnology Research Institute, Academy of Agricultural 
Science(Sichuan, China). DGBXT extract at 3.3 g/mL 
was produced according to Pharmacopoea Chinensis by 
Department of Traditional Chinese Medicine, Chengdu 
University of TCM (Sichuan, China). Chinese angelica 
granule and milkvetch root granule were produced by Sanjiu 
Modern Medicine Ltd. Ferulic acid and astragaloside 桇
were purchased from the National Institute for the Control of 
Pharmaceutical and Biological Products (Beijing, China).
2.2. Grouping and modeling
  Firstly, each mouse was irradiated by 2.0Gy 60Co and than 
had intraperitoneal injection with cyclophosphamide (Cy) 
50 mg/kg daily for three days. 24 hours after modeling, 
DGBXT decoction and granule were fed by intragastrical 
administration at 10 g/kg daily. Mice in normal control group 
and model group were fed by 1 mL of normal saline daily. It 
took seven consecutive days for administration.
2.3. Detection of ferulic acid and astragaloside 桇
  A waters 2695 liquid chromatograph system consisting 
of a quaternary pump, an autosampler and waters 
2996 photodiode array detector coupled with Empower 
chromatographic workstation was used. The analytical 
column was Dia- monsil C18 reversed-phase column (4.6 mm
伊150 mm, 5 毺m). The mobile phase was methanol-aqueous 
acetic acid. The detection wavelength of the photodiode 
array detector was set at 254 nm (Ferulic acid and 
astragaloside 桇); flow-rate: 1.0 mL/min.  
2.4. Determination of peripheral blood cells and bone marrow 
nucleated cells
  24 hours after the last administation, blood (10 毺L) was 
obtained from plexus venosus behind the eyeball, and 
diluted with EDTA (30 毺L). HS-18 type fully automated 
hematology analyzer (Italy) was used to detect peripheral 
blood cells. Single marrow cells were counted by leukocyte 
count assay under microscope.
2.5.The preparation of bone marrow nucleated cell suspension 
  24 hours after the last administration, mice were sacrificed 
with cervical dislocation. Femur was removed and bone 
marrow cells were rinsed with normal saline (1 mL) for 
suspension. 
2.6. Hematopoietic progenitor cells culture
  Bone marrow cells were plated at a concentration of 
105/mL on semisolid methylcellulose supplemented with 
30% fetal calf serum, 1% bovine serum albumin (BSA), 10-4 M 
2-mercaptoethanol, 2 mM L-glutamine, 50 ng/mL stem cell 
factor, 20 ng/mL IL-3, 3 U/mL erythropoietin (EPO), 20 ng/mL 
rm granulocyte macrophage colony stimulating factor (GM-
CSF) (PeproTech ,America), 20 ng/mL rm thrombopoient 
(TPO) ( PeproTech, America). Plates were cultured at 37 曟 in 
5% CO2 atmosphere. Colony-forming unit erythroid ( CFU-E) 
were counted under inverted phase contrast microscope 
after 3 days of culture. Burst-forming uniterythroid (BFU-E), 
colony-forming unit granulocyte macrophages (CFU-GM), 
colony-forming unit granulocyte macrophagecolony-
forming unit- megakaryocte (CFU-Meg) were counted after 7 
days of culture.
2.7. Cell cycle analysis 
  Single bone marrow cell suspension were centrifuged 
(1 000 r/min, 5 min). The supernatant was removed and 
precipitated cells were washed twice with PBS, and then 
fixed with 70% cold ethanol. Before detection cells were 
washed again with PBS twice, and blended with PBS 
(100 毺 L), and dyed with propidium iodide (Sigma, America) 
staining solution (4 曟, protection from light for  30 min). 
Then cell cycle was detected by flow cytometry. Data of 
every cell cycle phase were calculated in percentage.
2.8. Detection of bone marrow nucleated cells by sandwich 
ELISA 
  EPO, TPO and GM-CSF were detected by ELISA Kit (BioTech 
Sengxiong,shanghai). And OD value was measured at 492 nm.
2.9. Statistical analysis 
  All data were expressed as mean依SD. The one-way ANOVA 
was used to analyze differences among groups. P < 0.05 was 
considered to be statistically significant.
3. Results
3.1 Content of ferulic acid and astragaloside in different 
DGBXT formulation
  
  The results from fingerprints showed that there were 
significant difference in the content of ferulic acid and 
astragaloside 桇 between DGBXT decoction and granule 
formulation (Figure 1). The content level of astragaloside 桇 
in granule formulation was higher than that in decoction and 
the content  ratio of the active ingredient was near to 5÷1. 
As we known the weight ratio of astragalus and angelica 
in the traditional formula was also 5÷1 . The ratio of the 
ingredients in decoction was lower than that of granular 
formulation.
3.2. Effect on peripheral blood and bone marrow nucleated 
cell count 
  These results indicated that amount of WBC, RBC, HB, 
PLT and BMC in model group were significantly less than 
that of normal group (P<0.05). It confirmed the successful 
mice model of bone marrow suppression. Two DGBXD 
formulations could significantly improve peripheral blood 
and bone marrow cells of bone marrow suppression mice 
(P<0.05). But there was no significant difference between 
decoction group and granule group (Table 1).
Suchun Yan et al./Asian Pacific Journal of Tropical Medicine (2011)556-559558
Table 1  
Effect on peripheral blood and bone marrow nucleated cell count( Mean暲SD, n=6)
Group WBC(伊109/L)      RBC(伊1012/L) HB(伊g/L) PLT(伊109/L) BMC(伊109/L)
Normal 10.90依1.60 10.78依2.19 157.16依7.73 288.00依35.62 10.16依1.16
Model   1.05依0.42*   2.83依1.46* 101.66依2.06* 162.83依37.30*   2.00依1.26*
Decoction   7.06依2.22△   5.42依5.42△ 126.66依14.26△ 266.16依103.4△   3.16依1.47
Granule   8.08依6.10△   8.36依1.58△ 139.33依17.82△ 338.00依25.66△   9.33依2.58△
* P <0.05 vs. normal group；△P <0.05 vs. model group.
Table 2
Effect on colony yield of hematopoietic progenitor cells in vitro(Mean暲SD, n=6)
Groups BFU-E CFU-E CFU-Meg CFU-GM
Normal 56.17依5.71 126.50依8.09 85.67依4.76 81.33依8.21
Model 26.50依6.25* 63.33依6.38* 36.50依4.80* 20.83依3.25*
Decoction 35.50依8.64△ 75.33依7.34△ 42.33依2.34 32.83依3.43△
Granule 51.83依3.87△▲ 94.0依10.15△▲ 61.67依8.48△▲ 40.17依6.21△▲
* P <0.05 vs. normal group；△P <0.05 vs. model group；▲P <0.05 vs. decoction group.
Table 3
The effect on cell cycle (Mean暲SD, n=6).
Groups G0/G1 phase S phase G2/M phase
Normal 56.36依1.97 32.31依1.12 11.5依1.49
Model 72.21依2.10* 22.03依1.47* 6.57依0.89*
Decoction 64.88依2.01△ 24.83依2.41△ 8.15依0.36△
Granule 62.70依1.56△▲ 28.00依2.16△▲ 8.77依1.72△▲
  * P <0.05 vs. normal group；△P <0.05 vs. model group；▲P <0.05 vs. decoction group.
Figure 1. Finger print of ferulic acid and astragaloside 桇in different DGBXT formulation.
Peak 8: ferulic, peak13: astragaloside桇.
3.3. Effect on colony yield of hematopoietic progenitor cells 
in vitro 
   It showed that DGBXT decoction significantly boosted 
the yield of BFU-E, CFU-E and CFU-GM cultured in vitro 
except CFU-Meg (P<0.05). However granule formulation 
significantly increased the colony quantity of all progenitor 
cell lines and meanwhile was more effective(P<0.05)(Table 
1).
3.4. Effect on cell cycle 
  Table 3 showed that the quantity of G0/G1 phase cells 
was significantly increased and the amount of G2/M and S 
phase cells significantly decreased in model group(P<0.05). 
After treatment, G0/G1 phase cells in the bone marrow have 
been significantly decreased and G2/M and S phase cells 
significantly increased(P<0.05). And granule formulation was 
more effective than decoction(P<0.05).
3.5. Effect on TPO, EPO and GM-CSF of bone marrow 
stroma
   Table 4 indicated that DGBXT decoction and granule 
formulation could significantly decreased TPO, EPO and 
GM-CSF content of bone marrow stroma(P<0.05). In normal 
conditions, there are only a few cytokines in the bone 
marrow stroma. Due to the damage of bone marrow stromal 
by modeling, cytokines were significantly increased(P <0.05). 
After the treatment, cytokines in the micro-environment 
gradually declined to normal level. And granule formulation 
was more effective in boosting EPO than in boosting TPO and 
GM-CSF.
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4. Discussion
  The high infection of human cytomegalo virus can’t be 
controlled effectively, and traditional Chinese medicine 
has become a new alternative treatment. It can improving 
immune system and can inhabit virus infection[12]. It is 
reported that CMV-AD169 may be inhibited or killed by 
GCV and Astragalus membranaceus in vitro[13]. Our previous 
studies[14,15] showed that the active ingredient, Angelica 
polysaccharides in angelica and Astragalus astragaloside 桇 
in radix astragali both play an effective role in improving 
the colony-yield of hematopoietic progenitor/stem cells, 
promoting the gene expression of transcription factor 
GATA-1, boosting quiescent BMC to enter the cell cycle and 
then promoting cell proliferation. They can also promote 
the expression of anti-apoptotic protein Bcl-xL, inhibit 
apoptosis, and meanwhile influence the differentiation 
direction of progenitor cells. This study shows that DGBXT 
granule has far more rich content of ferulic acid and 
astragaloside 桇. Besides the ratio is more closed to the 
weight ratio of angelica and astragalus in the traditional 
formula. Therefore, the granule is more effective. 
  In addition, some researchers[16] compared the effective 
content between the decoction and granule formulation 
using high performance liquid chromatography, and studied 
the efficacy of two formulations in clinic. They also hold the 
same option with our experimental results that the granule 
formulation was more effective. Therefore, the reform of 
Chinese medicine formulations will greatly expand the use 
of traditional Chinese medicine.
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Table 4
Effect on TPO, EPO and GM-CSF of bone marrow stroma (Mean暲SD, n=6).
Groups TPO EPO GM-CSF
Normal 0.120依0.02 0.10依0.02 0.11依0.02
Model 0.53依0.13* 0.32依0.07* 0.54依0.13*
Decoction 0.27依0.13△ 0.23依0.05△ 0.25依0.11△
Granule 0.20依0.12△ 0.14依0.07△▲ 0.20依0.13△
* P <0.05 vs. normal group；△P <0.05 vs. model group；▲P <0.05 vs. decoction group.
